Liu L, Massey T E
Department of Pharmacology and Toxicology, Queen's University, Kingston, Ontario, Canada.
Carcinogenesis. 1992 Apr;13(4):533-9. doi: 10.1093/carcin/13.4.533.
In the present investigation, we have examined the role of lipoxygenases in the bioactivation of aflatoxin B1 (AFB1) in hepatic and extrahepatic tissues. The enzyme activities were evaluated by determining [3H]AFB1-DNA adduct formation. The results demonstrated that both purified soybean lipoxygenase and guinea-pig tissue cytosolic lipoxygenases were able to activate AFB1 to form [3H]AFB1-DNA adduct(s). The reaction was completely inhibited by nordihydroguaiaretic acid (NDGA, 0.1 mM), a lipoxygenase inhibitor and an antioxidant, but not by indomethacin (0.1 mM), an inhibitor of prostaglandin H synthase (PHS), indicating that this reaction is associated with lipoxygenase activity, and/or is involved in a peroxyl radical process. While purified lipoxygenase showed arachidonic acid (AA)-dependent properties, the omission of AA did not diminish guinea-pig tissue cytosolic [3H]AFB1-DNA adduct formation, possibly because AA was released from lipid particles by AFB1. Within the range of hemoglobin (Hb) concentrations found in lung, kidney and liver cytosols (1.4-11.1 microM) and microsomes (0-0.5 microM), neither pure Hb, nor Hb of cytosols or microsomes from whole blood caused detectable AA-dependent AFB1-DNA binding. This indicates that Hb, as a contaminant with quasi-lipoxygenase activity, did not contribute to AFB1 activation attributed to guinea-pig tissue lipoxygenases. [3H]AFB1 concentrations at half-maximal DNA binding rate of pulmonary cytochrome P450 monooxygenases (P450) and lipoxygenases were similar, though P450 had a much higher maximum DNA binding rate. Pulmonary microsomal PHS activity for AFB1 activation was too low for its half-maximal binding concentrations of [3H]AFB1 and maximum rate to be accurately determined. In kidney, maximum rates for lipoxygenase, PHS and P450 were similar, whereas half-maximal binding concentrations for reactions by lipoxygenase and P450 were lower compared to that of PHS. The half-maximal binding concentration of hepatic lipoxygenase was significantly lower than those for PHS and P450. Hepatic half-maximal binding concentrations for PHS and P450 were similar, though P450 had a much higher maximum rate than PHS and lipoxygenases. These data suggest that lipoxygenase-catalyzed AFB1 activation can occur at low AFB1 concentrations. This may be important in view of human exposure to low AFB1 concentrations and predominant lipoxygenase activity in human airway epithelial cells. When expressed per gram of tissue, renal and hepatic PHS activities and renal lipoxygenase activities for AFB1 activation were similar, and higher than the activity of pulmonary PHS, while pulmonary PHS activity for the oxidation of N,N,N',N'-tetramethyl-p-phenylenediamine (TMPD) was similar to that in liver and lower than that in kidney.(ABSTRACT TRUNCATED AT 400 WORDS)
在本研究中,我们检测了脂氧合酶在黄曲霉毒素B1(AFB1)于肝组织和肝外组织中的生物活化过程中的作用。通过测定[3H]AFB1-DNA加合物的形成来评估酶活性。结果表明,纯化的大豆脂氧合酶和豚鼠组织胞质脂氧合酶均能够激活AFB1以形成[3H]AFB1-DNA加合物。该反应被去甲二氢愈创木酸(NDGA,0.1 mM)完全抑制,NDGA是一种脂氧合酶抑制剂和抗氧化剂,但未被吲哚美辛(0.1 mM)抑制,吲哚美辛是前列腺素H合酶(PHS)的抑制剂,这表明该反应与脂氧合酶活性相关,和/或参与了过氧自由基过程。虽然纯化的脂氧合酶表现出花生四烯酸(AA)依赖性特性,但省略AA并未减少豚鼠组织胞质中[3H]AFB1-DNA加合物的形成,可能是因为AA被AFB1从脂质颗粒中释放出来。在肺、肾和肝细胞溶质(1.4 - 11.1 microM)和微粒体(0 - 0.5 microM)中发现的血红蛋白(Hb)浓度范围内,无论是纯Hb,还是全血中细胞溶质或微粒体的Hb,均未引起可检测到的AA依赖性AFB1-DNA结合。这表明,作为具有准脂氧合酶活性的污染物,Hb对豚鼠组织脂氧合酶引起的AFB1活化没有贡献。肺细胞色素P450单加氧酶(P450)和脂氧合酶在DNA结合率达到半数最大值时的[3H]AFB1浓度相似,尽管P450具有高得多的最大DNA结合率。肺微粒体中用于AFB1活化的PHS活性过低,以至于无法准确测定其[3H]AFB1的半数最大结合浓度和最大速率。在肾脏中,脂氧合酶、PHS和P450的最大速率相似,而脂氧合酶和P450反应的半数最大结合浓度低于PHS。肝脂氧合酶的半数最大结合浓度显著低于PHS和P450。肝中PHS和P450的半数最大结合浓度相似,尽管P450的最大速率比PHS和脂氧合酶高得多。这些数据表明,脂氧合酶催化的AFB1活化可在低AFB1浓度下发生。鉴于人类暴露于低AFB1浓度以及人类气道上皮细胞中占主导地位的脂氧合酶活性,这可能具有重要意义。当以每克组织表示时,肾和肝中用于AFB1活化的PHS活性以及肾脂氧合酶活性相似,且高于肺PHS的活性,而肺中用于氧化N,N,N',N'-四甲基对苯二胺(TMPD)的PHS活性与肝中的相似且低于肾中的。(摘要截短于400字)